5th Annual CNPN Symposium


A-H    |    K-0     |     P-Z                [PDF-print all]


Victoria Pando-Robles, National Public Health Institute, Mexico
Dr. Pando is an associate professor and Chair of the Proteomics Facility in the National Public Health Institute. She is also the President of Proteomics Society of Mexico (2012-2013). Since forming her group in 2009, the lab research is focused on understanding the pathogens-host interaction using proteomics.

Abstract: Quantifying the impact of dengue virus infection on monocyte cell line proteins


Paul Pavlidis, University of British Columbia.
Dr.Pavlidis is an Associate Professor of Psychiatry at the UBC Centre for High-Throughput Biology. His research interests arein neurogenomics and neuroinformatics, focusing on the analysis of large and complex genomics data sets and the development of databases, software and computational methods. He is also the Scientific Director of the Neuroinformatics Core for the NeuroDevNet Network of Centres of Excellence.

Abstract: Gene Multifunctionality and the Interpretation of Protein Networks


Natalie Strynadka, University of British Columbia.
Dr. Strynadka is a Professor of Biochemistry and Molecular Biology at the University of British Columbia. She uses a multidisciplinary structural biology approach to study the molecular details and function of membrane protein assemblies. Since forming her own group in 1997, she has received many accolades including being named a Medical Research Council of Canada Scholar, Canadian Institute of Health Research Scientist, Burroughs Wellcome New Investigator in the Pharmacological Sciences, NRC Steacie Prize recipient, Michael Smith Foundation for Health Research Senior Scholar, Canada Council of the Arts National Killam Fellow, and multiple awardee from the HHMI International Research Scholar program. She is also the holder of a Canada Research Tier 1 Chair and has been a fellow of the Royal Society of Canada since 2006.
Abstract: Structure-based Analysis of Bacterial Membrane Protein Assemblies


Paul Tempst Memorial Sloan-Kettering Cancer Center, New York.
Dr. Tempst has 35 years of experience in protein chemistry, biochemistry, molecular biology, and mass spectrometry, including postdoctoral studies at California Institute of Technology (1982-85), Assistant Professor at Harvard Medical School (1986-90), and Professor of Molecular Biology at Memorial Sloan-Kettering Cancer Center and at the Weill Graduate School of Cornell University (New York). He leads a proteomics team specialized in chromatin dynamics research and cancer biomarker discovery and has collaborated with investigators worldwide to identify novel interacting proteins and protein complexes. These include PDGF, Prions, NFkappaB, IkappaB, NF-E2, PI3K, mTOR, Raptor, p27kip, the SNAREs, Mediator, Elongator, Polycomb, RSC, Swi/Snf, Exosome, Histone deacetylases, methylases, demethylases and ubiquitinating complexes. He has published over 300 peer-reviewed papers, mostly on proteomics methods and applications, and owns 9 patents on related technologies. Recently, his lab pioneered the evaluation and use of protease activities as biomarkers for cancer.
Abstract: Aminopeptidase Activities as Biomarkers for Cancer


Luis Teran, Universidad Nacional Autonoma de Mexico.
Professor Luis M. Teran (MD, PhD) is the head of Immunogenetics and Allergy at the Instituto Nacional de Enfermedades Respiratorias and the Universidad Nacional Autonoma de Mexico (School of Medicine) and leads a multidisciplinary research team. His research on proteomics has focused on both viral respiratory infections and allergic disease.

Abstract: Abstract: Proteomics in Respiratory Virus Disease


Pierre Thibault, Université de Montréal.
Dr. Thibault heads the Proteomics facility at Institute for Research in Immunology & Cancer. His group has pioneered the use and application of label-free quantitative proteomics. His research program is centered on mass spectrometry-based proteomics to gain a further understanding of the molecular mechanisms and post-translational modifications that regulate the function and translocation of proteins involved in immunity and signalling of cancer cells.
Abstract: Emerging Roles of Protein SUMOylation Unveiled Using SUMO Remnant Affinity Enrichment and Quantitative Proteomics


David Vocadlo, Simon Fraser University.
Dr. Vocadlo is Professor and Canada Research Chair in Chemical Glycobiology at Simon Fraser University. He leads an interdisciplinary team in developing and using chemical probes to understand the functional roles of various glycan structures as well as to uncover new approaches to target such glycans for the purposes of treating diseases including cancer and neurodegeneration. He is also a co-founder and consulting Chief Scientific Officer of Alectos Therapeutics, a biotechnology company that has partnered with Merck to develop small-molecule therapies for Alzheimer disease. His work at the interface of chemistry and biology has been recognized through awards including Canada’s Top 40 Under 40 and a 2011 EWR. Steacie Memorial Fellowship.      
Abstract: Mass Spectrometry Activity Based probes for Glycoproteomics


Marc Wilkins, Systems Biology Initiative, School of Biotechnology and Biomolecular Sciences, University of New South Wales.
Dr. Wilkins developed the concept of the proteome in 1994 and coined the term. In 1997 he co-wrote and co-edited the first book on proteomics (4,000+ copies sold). This, and a series of other seminal works, substantially contributed to the establishment of the proteome and of proteome research. Proteomics is now widely adopted, and is included in biochemistry textbooks and the undergraduate curriculum. Current research interests are (i) the role of protein methylation in the proteome (ii) the dynamics of protein interaction networks and (iii) the co-analysis of next-generation sequencing data in the context of networks.
Abstract: The Dynamics of the Interactome

{end} Back to Page 1 >>
2013 Sponsors
Genome BC M.Smith C M Genome PQ K-Prime MRM HUPO NEB AB Sciex Bruker B S I Thermo Agilent BCPN Uvic PC Genome Canada